NDC properties for "adalimumab-adaz 80 MG per 0.8 ML Auto-Injector" (RxCUI 2641662)
About this data
The tables show NDC propoerties for adalimumab-adaz 80 MG per 0.8 ML Auto-Injector with the RxCUI 2641662
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for adalimumab-adaz 80 MG per 0.8 ML Auto-Injector (RxCUI 2641662)
| BLA | BLA761071 |
|---|---|
| MMSL_CODE | BD39596 |
| RxCUI | 2641662 |
| SPL_SET_ID | 3468792f-63ef-4916-8ed1-8214f327d9dd |
| Prescribable Synonym | adalimumab-adaz 80 MG in 0.8 ML Auto-Injector |
| RXNAV_STR | 0.8 ML adalimumab-adaz 100 MG/ML Auto-Injector |
| RxNorm Name | 0.8 ML adalimumab-adaz 100 MG/ML Auto-Injector |
| RxNorm Synonym | adalimumab-adaz 80 MG per 0.8 ML Auto-Injector |
| Related queries | Interactions (for RxCUI 2641662) |
NDC Properties
NDC Item 61314032520
| NDC 9 | 61314-325 |
|---|---|
| NDC 10 | 61314-325-20 |
| NDC Item | 61314032520 |
| Packaging | 2 SYRINGE in 1 CARTON (61314-325-20) / .8 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 866575 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-06 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-325 |
NDC Item 61314032596
| NDC 9 | 61314-325 |
|---|---|
| NDC 10 | 61314-325-96 |
| NDC Item | 61314032596 |
| BLA | BLA761071 |
| FDA SPL set id | 866575 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-06 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-325 |
NDC Item 61314032520
| NDC 9 | 61314-325 |
|---|---|
| NDC 10 | 61314-325-20 |
| NDC Item | 61314032520 |
| Packaging | 2 SYRINGE in 1 CARTON (61314-325-20) / .8 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 866575 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-06 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-325 |
NDC Item 61314032596
| NDC 9 | 61314-325 |
|---|---|
| NDC 10 | 61314-325-96 |
| NDC Item | 61314032596 |
| BLA | BLA761071 |
| FDA SPL set id | 866575 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-06 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-325 |